134 results
8-K
EX-99.1
CSBR
Champions Oncology Inc
12 Mar 24
Champions Oncology Reports Quarterly Revenue of $12.0 Million
4:31pm
.
Research and development expense for the three-months ended January 31, 2024 was $2.2 million, a decrease of $1.0 million or 31.7%, compared to $3.2 … volume due to some operational inefficiencies.
Research and development expense for the nine-months ended January 31, 2024 was $7.5 million, a decrease
8-K
EX-99.1
CSBR
Champions Oncology Inc
12 Dec 23
Champions Oncology Reports Quarterly Revenue of $11.6 Million
4:14pm
October 31, 2022. The lower margin resulted from lower revenue against a generally unchanged cost base.
Research and development expense for the six … services
Research and development
Sales and marketing
General and administrative
Income (loss) from operations
Other loss
Loss before provision
8-K
EX-99.1
5b2dk1o2z
13 Sep 23
Champions Oncology Reports Quarterly Revenue of $12.6 Million
4:00pm
8-K
EX-99.1
y995wd646krnmwzq252s
24 Jul 23
Champions Oncology Reports Quarterly Revenue of $13.1 Million
4:04pm
8-K
EX-99.1
p4e2n9sx 25lw
13 Dec 22
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
4:01pm
8-K
EX-99.1
o4crrt
8 Sep 22
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
3:59pm
8-K
EX-99.1
66p024zv35c
21 Jul 22
Champions Oncology Reports Quarterly Revenue of $12.9 Million
3:59pm
8-K
EX-99.1
niw3w41cwm4vb 8qg
15 Mar 22
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million
4:31pm
8-K
EX-99.1
8ajas
13 Dec 21
Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
3:59pm
8-K
EX-99.1
9ynkkmc
13 Sep 21
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
4:17pm